Resection after neoadjuvant therapy?
Monday, 30 November 2026, 9:45 am
Simon Bach
Simon Bach’s work centres on response-adapted treatment after neoadjuvant therapy. The TREC/STAR-TREC strategy deliberately uses radiotherapy or chemoradiotherapy to induce tumour regression, then selects watch-and-wait, transanal excision or TME according to clinical response. Its success depends on precise response assessment and rigorous surveillance, with timely salvage surgery for local regrowth.
About Simon Bach
Simon Bach is Professor of Surgery at University College London, Director of UCL’s Division of Surgery and Interventional Science, and Honorary Consultant Colorectal Surgeon at University College London Hospitals. He is internationally recognised for his work in rectal cancer and organ preservation. Through landmark studies including TREC and STAR-TREC, he has helped build the evidence base for safely sparing carefully selected patients radical rectal surgery.
European Colorectal Congress 2026
See the full program and secure your seat.
You might also be interested in
-
What’s new in endoscopic surgery?
Elena De Cristofaro highlights how advanced endoscopic submucosal dissection (ESD) is expanding the boundaries of minimally invasive treatment for increasingly challenging lesions.
-
Implementing CME and CVL nationwide. What is the new standard?
Jurriaan Tuynman posits that CME and CVL should become the new nationwide standard, as they have the capacity to enhance oncological outcomes…
-
Strategies for flexure cancers: extended or limited resection?
Patricia Tejedor argues that surgery for flexure cancers should be tailored to tumor location and vascular anatomy rather than defaulting to an…